Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Globigen Dia Stop is a veterinary dietary supplementary feed and feed additive formulated to stabilize water and electrolyte balance, support physiological digestion, and promote gut health in young farm animals, particularly calves, lambs, and kids suffering from or at risk of diarrhea. Developed by EW Nutrition, the formulation contains a synergistic blend of dextrose, sodium chloride, sodium bicarbonate, potassium chloride, yeast products, dried egg products containing natural egg-derived immunoglobulins (IgY), and a vitamin premix (Vitamins A, D3, and E). The egg immunoglobulins work locally within the intestinal tract to bind pathogens, reduce pathogen pressure, and support local gut immunity, while the electrolytes and dextrose replenish lost fluids and restore metabolic balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Globigen Dia Stop.